Decisions made before your ophthalmic trial begins can have lasting implications for its design, regulatory path, and execution. Are you bringing the right expertise into those conversations early enough?
View this live panel discussion on when to engage your CRO and how early collaboration can help you anticipate challenges before they become costly setbacks. Hear clinical, nonclinical, regulatory, and sponsor perspectives on the decisions that shape your development program.
What you’ll take away:
• When to bring a CRO into your program and which decisions benefit from early input
• How to connect non-clinical planning, clinical study design, and regulatory strategy
• Key considerations for endpoint selection, ocular safety, and protocol design
• How to work with your CRO as a development partner before trial execution begins
Panelists:
• David Kleinman, MD, MBA
• Jeremy Brace, Regulatory Consultant
• Kathleen Krenzer, OD, PhD, DABT, Clinical Scientist & Non-Clinical Consultant
• Brian Levy, OD, CEO of Vitranu, Panelist and Moderator
LISTEN HERE:
Learn more or connect with the iuvo Clinical team: